Related Experiment Video
Updated: Jun 15, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
A bias correction in testing treatment efficacy under informative dropout in clinical trials
Fanhui Kong1, Yeh-Fong Chen, Kun Jin
1Division of Biometrics I, Food and Drug Administration, Silver Spring, Maryland 20993, USA. fanhui.kong@fda.hhs.gov
Abstract:
In clinical trials of drug development, patients are often followed for a certain period of time, and the outcome variables are measured at scheduled time intervals. The main interest of the trial is the treatment efficacy at a prespecified time point, which is often the last visit. In such trials, patient dropout is often the major source for missing data. With possible informative patient dropout, the missing information often causes biases in the inference of treatment efficacy. In this article, for a time-saturated treatment effect model and an informative dropout scheme that depends on the unobserved outcomes only through the random coefficients, we propose a grouping method to correct the biases in the estimation of treatment effect. The asymptotic variance estimator is also obtained for statistical inference. In a simulation study, we compare the new method with the traditional methods of the observed case (OC) analysis, the last observation carried forward (LOCF) analysis, and the mixed model repeated measurement (MMRM) approach, and find it improves the current methods and gives more stable results in the treatment efficacy inferences.
Insights
This study introduces a new grouping method to address informative patient dropout in clinical trials, improving treatment efficacy estimation. The method corrects biases caused by missing data, offering more stable and reliable inferences compared to traditional approaches.
Area of Science:
- Clinical Trials
- Biostatistics
- Longitudinal Data Analysis
Background:
- Patient dropout is a significant source of missing data in clinical trials.
- Informative patient dropout can introduce bias into treatment efficacy estimations.
- Traditional methods like Observed Case (OC) and Last Observation Carried Forward (LOCF) may not adequately handle informative dropout.
Purpose of the Study:
- To propose a novel grouping method for correcting bias in treatment effect estimation.
- To address informative dropout schemes dependent on unobserved outcomes via random coefficients.
- To provide an asymptotic variance estimator for statistical inference.
Main Methods:
- Development of a grouping method for bias correction in time-saturated treatment effect models.
- Incorporation of an informative dropout scheme dependent on random coefficients.
- Derivation of an asymptotic variance estimator for robust statistical inference.
Main Results:
- The proposed grouping method effectively corrects biases in treatment effect estimation.
- The new method demonstrates improved stability and accuracy compared to OC, LOCF, and Mixed Model Repeated Measurement (MMRM) approaches.
- Simulation studies confirm the superiority of the proposed method in handling informative dropout.
Conclusions:
- The proposed grouping method offers a significant advancement in analyzing clinical trial data with informative patient dropout.
- This approach enhances the reliability of treatment efficacy inferences, crucial for drug development.
- The method provides a more stable and accurate alternative to existing statistical techniques for longitudinal data analysis.
Related Concept Videos
Blinding
Blind Procedures
Bias in Epidemiological Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bias
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
Censoring Survival Data